The United States continues to face a public health crisis of opioid-related harm, the effects of which could be dramatically reduced through increased access to opioid agonist therapy with the medications methadone and buprenorphine. Despite overwhelming evidence of their efficacy, unduly restrictive federal, state, and local regulation significantly impedes access to these life-saving medications. This commentary outlines immediate, concrete steps that federal, state, and local governments can take to change law from barrier to facilitator of evidence-based treatment for opioid use disorder.
Recent Abstracts
Model Kentucky Ordinance Establishing a County Opioid Abatement Advisory Council
The invisible pain: Gaps in Brazil’s public health system data on Menstrual and…
Exploring the Interface Between Birth Registration and Citizenship Determination: A Scoping Study in…
A dor invisível: lacunas nos dados do SUS sobre dor menstrual e pélvica
Catalyzing Support for CRVS Improvement – Examples from the Data for Health Initiative
A Guide to Designing Contextualized Civil Registration and Vital Statistics E-Learning Courses
Guide to Developing Standard Operating Procedures (SOPs) for Civil Registration Using a Case-Based…
Building Safe and Healthy Communities
Uncovering the Hidden Risks of PM 2.5 Exposure Among School-Aged Children in Jakarta
Strengthening Health Systems to Address Air Pollution in Ethiopia